Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Colorectal Neoplasms × spartalizumab × Clear all

Phase

Status

Completed 5 Terminated 4 Unknown 3 Recruiting 3 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Rectal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Nasopharyngeal Carcinoma 1 Lung Neoplasms 1 Locally Advanced Low Rectal Adenocarcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Advanced Digestive System Tumor 1

Interventions

Bevacizumab 29 Oxaliplatin 15 Irinotecan 13 Capecitabine 13 Leucovorin 12 Fluorouracil 11 HMPL-013 8 Cetuximab 6 trifluridine tipiracil drug combination 5 irinotecan sucrosofate 4 Specimen Handling 4 Folfox protocol 4 Drug Therapy 4 trametinib 3 toripalimab 3 tislelizumab 3 Standard of Care 3 Mitomycin 3 Magnetic Resonance Spectroscopy 3 IFL protocol 3 Colonoscopy 3 Blood Specimen Collection 3 Biopsy 3 zanidatamab 2 tipiracil 2 sotorasib 2 regorafenib 2 pembrolizumab 2 dehydroftorafur 2 XELOX 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07365592 2026-01-26

Neo-CD

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡